The disclosure provides methods for treating a subject suffering from a disease associated with sodium channel activity. The method comprises administering to the subject a therapeutically effective amount of a compound according to Formula II or Formula III described in the specification, or a pharmaceutically acceptable salt, prodrug, tautomer, stereoisomer, hydrate, or solvate thereof.
该披露提供了治疗患有与
钠通道活性相关的疾病的方法。该方法包括向受试者施用规范中描述的Formula II或Formula III中的化合物的治疗有效量,或其药用可接受的盐、前药、互变异构体、立体异构体、
水合物或溶剂化合物。